Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / MHUA - MHUA subsidiary partners with Getein Biotech to produce and sell Covid-19 antigen test kits and IVDs

MHUA - MHUA subsidiary partners with Getein Biotech to produce and sell Covid-19 antigen test kits and IVDs

Meihua International Medical Technologies Co. Ltd.
  • Meihua International Medical Technologies ( NASDAQ: MHUA ) announced the company's subsidiary Jiangsu Huadong Medical Device Industrial has entered into a strategic cooperation agreement with Getein Biotech to jointly produce and sell Covid-19 antigen test kits and other in vitro diagnostics (or IVD) products.
  • The production base is equipped with 52 new fully automated Covid-19 antigen test kit production lines.
  • The exponential rise in Covid-19 cases during early December of 2022 followed by China's announced relaxations in its pandemic control and prevention policies has led to a nationwide shortage of antigen test kits.

For further details see:

MHUA subsidiary partners with Getein Biotech to produce and sell Covid-19 antigen test kits and IVDs
Stock Information
Company Name: Meihua International Medical Technologies Co. Ltd.
Stock Symbol: MHUA
Market: NASDAQ
Website: meihuamed.com
Menu
MHUA MHUA Quote MHUA Short MHUA News MHUA Articles MHUA Message Board
Get MHUA Alerts

News, Short Squeeze, Breakout and More Instantly...